Impact of MRI Timing on Tumor Volume and Anatomic Displacement for Brain Metastases Undergoing Stereotactic Radiosurgery
Brain metastases affect up to 30% of all cancer patients and are the most common neurological complication of cancer. Lung cancer, breast cancer, kidney cancer and melanoma are the most common primary tumors that metastasize to the brain. Prognosis with this diagnosis is still considered to be poor; however, subsets of patients can be identified based on prognostic factors who can live well beyond expectations and several years beyond diagnosis with limited brain metastases. During this conference Dr. Tugce Kutuk will discuss the basic principles of stereotactic radiosurgery and explain his clinical experience at Miami Cancer Institute.
Commercial Supporter
Baptist Health gratefully acknowledges the commercial support provided by Elekta for this activity.
Target Audience
Neurosurgeons, medical physicists, radiation oncologists, neuro-otolaryngologists, nurses and advanced practice registered nurses.
Learning Objectives
- Utilize MRI to assess the size of lesions to determine treatment plans.
- Implement the metrics used in assessing plan quality in Gamma Knife® treatment strategies.
Tugce Kutuk, M.D.
Department of Radiation Oncology
Miami Cancer Institute
Baptist Health South Florida
D. Jay Wieczorek, Ph.D.
Senior Physicist
Department of Radiation Oncology
Miami Cancer Institute
Baptist Health South Florida
Tugce Kutuk, M.D., and D. Jay Wieczorek, Ph.D., faculty for this educational activity, have no relevant financial relationships with ineligible companies* to disclose, and have indicated that the presentation or discussion will not include off-label or unapproved product usage.
Michael McDermott, M.D., conference director for this educational event, is a consultant with Deinde Medical.
Rupesh Kotecha, M.D., conference director for this educational event, has received honoraria from Elekta AB, Accuray, Viewray, Novocure and Elseivier. He has received research support from Medtronic, B. Earth Diagnostics, Novocure, Exelixis, CT Medical, AstraZeneca and Viewray. He is also on the speakers’ bureau with Novocure.
All of the relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.
*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
Required Hardware/Software
PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| |||||||
Mobile UsersThis site is supported on the following mobile devices:
| |||||||
Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |